POWW - Vertex Energy Exela Technologies lead premarket gainers

Ocuphire Pharma (OCUP) +71% after Phase 2 VEGA-1 trial in presbyopia meets endpoints.Vertex Energy (VTNR) +43% as Clean Harbors to acquire  certain assets.Verb Technology Company (VERB) +37%.Bridgeline Digital (BLIN) +29%.AST SpaceMobile (ASTS) +22%.Exela Technologies (XELA) +22% on $150 million new at-the-market equity program.Powerbridge Technologies (PBTS) +21%.LMP Automotive Holdings (LMPX) +19% on Q1 results.Predictive Oncology (POAI) +18%.BioHiTech Global (BHTG) +15%.Xcel Brands (XELB) +14%.HUTCHMED (China) Limited (HCM) +13%.Bit Brother Limited (BTB) +12%.MingZhu Logistics Holdings Limited (YGMZ) +11% on regaining Nasdaq compliance.Inpixon (INPX) +10%.SunLink Health Systems (SSY) +9%.AMMO (POWW) +8% on Q4 results.Atea Pharmaceuticals (AVIR) +8% on its AT-527 phase 2 interim analysis.Medicenna Therapeutics (MDNA) +7%.Datasea (DTSS) +7%.Stable Road Acquisition (SRAC) +7%.Eloxx Pharmaceuticals (ELOX) +6%.Tattooed Chef (TTCF) +5%.ServiceSource International (SREV) +5%.

For further details see:

Vertex Energy, Exela Technologies lead premarket gainers